These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Seeking the perfect match. HLA and transplantation. Tait BD Med J Aust; 1993 Nov; 159(10):696-700. PubMed ID: 8232014 [No Abstract] [Full Text] [Related]
26. Improving the outcome of unrelated donor stem cell transplantation by molecular matching. Shaw BE; Madrigal JA; Potter M Blood Rev; 2001 Dec; 15(4):167-74. PubMed ID: 11792117 [TBL] [Abstract][Full Text] [Related]
27. Human leukocyte antigen and its role in transplantation biology. Trivedi VB; Dave AP; Dave JM; Patel BC Transplant Proc; 2007 Apr; 39(3):688-93. PubMed ID: 17445574 [TBL] [Abstract][Full Text] [Related]
28. World Marrow Donor Association guidelines for use of HLA nomenclature and its validation in the data exchange among hematopoietic stem cell donor registries and cord blood banks. Bochtler W; Maiers M; Oudshoorn M; Marsh SG; Raffoux C; Mueller C; Hurley CK Bone Marrow Transplant; 2007 Jun; 39(12):737-41. PubMed ID: 17438587 [TBL] [Abstract][Full Text] [Related]
29. Domestic and foreign donor candidates result in differential probability of matching minor histocompatibility antigens--relevance of selection for hematopoietic stem cell transplantation. Turpeinen H; Volin L; Partanen J Tissue Antigens; 2009 Mar; 73(3):236-41. PubMed ID: 19254253 [TBL] [Abstract][Full Text] [Related]
30. Tissue typing for hematopoietic cell transplantation: HLA-DQB1 typing should be included. Horn PA; Elsner HA; Blasczyk R Pediatr Transplant; 2006 Sep; 10(6):753-4. PubMed ID: 16911505 [No Abstract] [Full Text] [Related]
31. Maintaining updated DNA-based HLA assignments in the National Marrow Donor Program Bone Marrow Registry. Maiers M; Hurley CK; Perlee L; Fernandez-Vina M; Baisch J; Cook D; Fraser P; Heine U; Hsu S; Leffell MS; Mauer D; Noreen H; Tang T; Trucco M; Yang SY; Hartzman RJ; Setterholm M; Winden T; Shepherd D; Hegland J Rev Immunogenet; 2000; 2(4):449-60. PubMed ID: 12361088 [TBL] [Abstract][Full Text] [Related]
32. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150 [TBL] [Abstract][Full Text] [Related]
33. [Search for non-relative donor by the Russian register of bone marrow donors]. Zaretskaia IuM; Khamaganova EG; Aleshchenko SM; Murashova LA Ter Arkh; 2002; 74(7):30-5. PubMed ID: 12181831 [TBL] [Abstract][Full Text] [Related]
35. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Greinix HT; Faé I; Schneider B; Rosenmayr A; Mitterschiffthaler A; Pelzmann B; Kalhs P; Lechner K; Mayr WR; Fischer GF Bone Marrow Transplant; 2005 Jan; 35(1):57-62. PubMed ID: 15531903 [TBL] [Abstract][Full Text] [Related]
36. A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. Hurley CK; Fernandez-Vina M; Hildebrand WH; Noreen HJ; Trachtenberg E; Williams TM; Baxter-Lowe LA; Begovich AB; Petersdorf E; Selvakumar A; Stastny P; Hegland J; Hartzman RJ; Carston M; Gandham S; Kollman C; Nelson G; Spellman S; Setterholm M Hum Immunol; 2007 Jan; 68(1):30-40. PubMed ID: 17207710 [TBL] [Abstract][Full Text] [Related]
37. The impact of the HLA-system in clinical medicine. van Rood JJ Schweiz Med Wochenschr; 1993 Jan; 123(3):85-92. PubMed ID: 8426953 [TBL] [Abstract][Full Text] [Related]